These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 11823290)

  • 1. Benzodiazepine discontinuation in generalized anxiety disorder.
    Gupta R; Gupta N; Avasthi A
    Am J Psychiatry; 2002 Feb; 159(2):321-2. PubMed ID: 11823290
    [No Abstract]   [Full Text] [Related]  

  • 2. Is imipramine or buspirone treatment effective in patients wishing to discontinue long-term benzodiazepine use?
    Sontheimer DL; Ables AZ
    J Fam Pract; 2001 Mar; 50(3):203. PubMed ID: 11252203
    [No Abstract]   [Full Text] [Related]  

  • 3. Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.
    Rickels K; DeMartinis N; García-España F; Greenblatt DJ; Mandos LA; Rynn M
    Am J Psychiatry; 2000 Dec; 157(12):1973-9. PubMed ID: 11097963
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Failure of buspirone to manage benzodiazepine withdrawal.
    Schweizer E; Rickels K
    Am J Psychiatry; 1986 Dec; 143(12):1590-2. PubMed ID: 2878622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Dependence on benzodiazepine and treatment of withdrawal syndrome].
    Sep-Kowalikowa B; Czucha M
    Psychiatr Pol; 2002; 36(6 Suppl):347-57. PubMed ID: 12647459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Efficacy and withdrawal of clobazam, lorazepam and buspirone in the treatment of anxiety disorders].
    Lemoine P; Rouillon F; Pouget D
    Encephale; 1996; 22(6):461-7. PubMed ID: 10901839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term anxiolytic therapy: the issue of drug withdrawal.
    Lader M
    J Clin Psychiatry; 1987 Dec; 48 Suppl():12-6. PubMed ID: 2891684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The comparison of tianeptine and carbamazepine in benzodiazepines withdrawal symptoms].
    Kornowski J
    Psychiatr Pol; 2002; 36(6 Suppl):311-8. PubMed ID: 12647454
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Switching from benzodiazepines to buspirone using a tapered overlap method in generalized anxiety disorder.
    Arató M
    J Clin Psychiatry; 2001 Aug; 62(8):657-8. PubMed ID: 11561943
    [No Abstract]   [Full Text] [Related]  

  • 10. Benzodiazepine dependence: management of discontinuation.
    Rickels K; Case WG; Schweizer E; Garcia-Espana F; Fridman R
    Psychopharmacol Bull; 1990; 26(1):63-8. PubMed ID: 1973546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Resistance to the anti-anxiety effect of buspirone in patients with a history of benzodiazepine use.
    Schweizer E; Rickels K; Lucki I
    N Engl J Med; 1986 Mar; 314(11):719-20. PubMed ID: 2869408
    [No Abstract]   [Full Text] [Related]  

  • 12. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-adrenergic blocking drugs in anxiety and stress.
    Noyes R
    Psychiatr Clin North Am; 1985 Mar; 8(1):119-32. PubMed ID: 2859576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term treatment of anxiety and risk of withdrawal. Prospective comparison of clorazepate and buspirone.
    Rickels K; Schweizer E; Csanalosi I; Case WG; Chung H
    Arch Gen Psychiatry; 1988 May; 45(5):444-50. PubMed ID: 2895993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The withdrawal syndrome in benzodiazepine dependence and its management].
    Străulea AO; Chiriţă V
    Rev Med Chir Soc Med Nat Iasi; 2009; 113(3):879-84. PubMed ID: 20191849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzodiazepine withdrawal syndrome.
    Lader M; Morton S
    Br J Psychiatry; 1991 Mar; 158():435-6. PubMed ID: 1674667
    [No Abstract]   [Full Text] [Related]  

  • 17. The psychopharmacology of anxiety.
    Nutt DJ
    Br J Hosp Med; 1996 Feb 21-Mar 5; 55(4):187-91. PubMed ID: 8777498
    [No Abstract]   [Full Text] [Related]  

  • 18. A risk-benefit assessment of buspirone in the treatment of anxiety disorders.
    Pecknold JC
    Drug Saf; 1997 Feb; 16(2):118-32. PubMed ID: 9067123
    [TBL] [Abstract][Full Text] [Related]  

  • 19. International study of expert judgment on therapeutic use of benzodiazepines and other psychotherapeutic medications: IV. Therapeutic dose dependence and abuse liability of benzodiazepines in the long-term treatment of anxiety disorders.
    Uhlenhuth EH; Balter MB; Ban TA; Yang K
    J Clin Psychopharmacol; 1999 Dec; 19(6 Suppl 2):23S-29S. PubMed ID: 10587281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term benzodiazepine use and depression.
    Nathan RG; Robinson D; Cherek DR; Davison S; Sebastian S; Hack M
    Am J Psychiatry; 1985 Jan; 142(1):144-5. PubMed ID: 2857068
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.